Professors Matthew Higgins and Michael Dustin from the University of Oxford, Prof Gavin Wright from the University of York, and Professors Shiroh Iwanaga and Hisashi Arase from Osaka University have secured a Wellcome Collaborative Award for their study \u201cHow do RIFINs and STEVORs modulate human immunity during malaria?\u201d
A new collaboration between Oxford, Brazil and Pakistan has been funded by the Bill & Melinda Gates Foundation. The partnership will provide researchers with de-identified health data from two of the worlds global COVID-19 hotspots to increase understanding of COVID-19 in these communities and help accelerate the management of the disease.
Interrogating metabolic crosstalk in the tumour-bone microenvironment, new research from the Edwards group shows how the pentose phosphate pathway contributes to prostate cancer bone metastasis.
Oxford is one of 28 sites that will benefit from over \u00a3160 million awarded over five years to expand early phase clinical research for the benefit of NHS patients.
People are at the heart of NDORMS and as such the department is dedicated to fostering an inclusive and supportive culture for all its staff and students. Two new initiatives have been recently launched; the mediation service, and a mental health first aiders programme.
The European Medicines Agency has announced the establishment of the Data Analysis and Real World Interrogation Network (DARWIN EU\u00ae) to support better decision making on the development and effectiveness of medicines and vaccines.
Professors Stephanie Dakin and Paul Bowness have been announced as 2021 recipients of the Novartis Institutes for BioMedical Research (NIBR) Global Scholars Program (NGSP).
An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as \u2018pins\u2019) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.
Moving to the University of Oxford with the Arthritis Therapy Acceleration Programme (A-TAP) will help accelerate the discovery of new treatments for inflammatory diseases.
A new study reveals the existence of a powerful ally in the fight against cardiovascular disease, a protective subset of vascular macrophages expressing the C-type lectin receptor CLEC4A2, a molecule which fosters \u201cgood\u201d macrophage behaviour within the vessel wall.
Sally Hopewell and John Christianson have been awarded the title of \u2018Full Professor\u2019 in the University of Oxford\u2019s Recognition Of Distinction Scheme 2021.
The Kennedy Institute for Rheumatology and the Institute of Developmental and Regenerative Medicine announce the launch of the Oxford-Zeiss Centre of Excellence, providing state-of-the-art imaging technologies to lead future discoveries in global health and disease.
Researchers in the Centre for OA Pathogenesis Versus Arthritis at the Kennedy Institute of Rheumatology and Imperial College London are looking to recruit adults with painful hand osteoarthritis for an observational study to help uncover why people living with the condition experience different patterns of pain.
![\"Mosquito](\"https://www.ndorms.ox.ac.uk/news/oxford-researchers-awarded-funding-to-study-the-immune-response-to-malaria/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n